Boston Heart Diagnostics

company

About

Boston Heart Lab is a heart health management company that provides cardiovascular disease (CVD) management.

  • 51 - 100

Details

Last Funding Type
Series Unknown
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2007
Number Of Employee
51 - 100
Operating Status
Active

Boston Heart Lab is a healthcare company that provides cardiovascular disease (CVD) management. Through there combination of proprietary lipid testing capability, sophisticated tools, advanced therapy guidelines, and patient support services, they are providing physicians, patients, and pharmaceutical companies with viable disease management. Unlike other lipid testing companies that are focused on the primary screening market for CVD, their proprietary testing technology allows for the ongoing monitoring of a patient's disease and precise determination of the most appropriate pharmaceutical alternatives. They can provide unique, personalized treatment options to patients with dyslipidemia to determine the efficacy of lipid adjusting drugs in most cases within the first 6 weeks of treatment. Competing methods usually need 6 months.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
Boston Heart Diagnostics has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 1, 2011 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2011 Series Unknown 1 Detail
Jan 1, 2009 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Boston Heart Diagnostics is funded by 1 investors. Keiretsu Forum are the most recent investors.
Investor Name Lead Investor Funding Round
Keiretsu Forum Series Unknown